Peptide ligands can remove process- and product-related impurities from gene therapies better than protein ligands.
Researchers have developed a new methodology that uses artificial intelligence (AI) tools to identify and count target viruses more efficiently than previous techniques. The new approach can be used ...
Switzerland's DINAMIQS receives Swissmedic approval for GMP viral vector production, becoming the country's first fully ...
High-throughput virology, design of experiments, and small-molecule production enhancers optimize yield and increase ...
Viral vector manufacturing continues to face challenges in delivering consistent quality and achieving high productivity at scale. This webinar will highlight how CDMO innovation drives improvements ...
SK pharmteco today announced a strategic partnership with Axle Informatics and the National Institutes of Health (NIH) to advance the development of gene therapies for rare diseases. This partnership, ...
LumaCyte today announced that its analytical approach has been included in the newly published International Organization for Standardization (ISO) global standard for gene delivery systems, ISO 16921 ...
Researchers at North Carolina State University have developed an AI-enhanced electrochemical sensing method to quickly and accurately quantify viral vectors used in gene therapies. The approach uses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results